glp-1 weight loss explained with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans GLP-1R Agonists for Weight Loss

A 2017 placebo-controlled clinical trial concluded that 5% Cubosomal ALA is an effective and safe modality for improving aging face. When adult women applied an ALA treatment to one side of their faces for six months, the majority experienced significant improvements, including increased epidermal thickness, which contributes to skins texture and tone

The research was approved by the University of Kufas institutional ethics board (8241/2021) and the Najaf Health Directorate-Training and Human Development Center (Document No.18378/ 2021)

Julianna Lindsey (06:13.493) Yes

Intended Use: This product is intended strictly for qualified laboratory researchers